174 related articles for article (PubMed ID: 15298722)
1. Monoclonal antibodies as effective therapeutic agents for solid tumors.
Hinoda Y; Sasaki S; Ishida T; Imai K
Cancer Sci; 2004 Aug; 95(8):621-5. PubMed ID: 15298722
[TBL] [Abstract][Full Text] [Related]
2. In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.
Larbouret C; Robert B; Navarro-Teulon I; Thèzenas S; Ladjemi MZ; Morisseau S; Campigna E; Bibeau F; Mach JP; Pèlegrin A; Azria D
Clin Cancer Res; 2007 Jun; 13(11):3356-62. PubMed ID: 17545543
[TBL] [Abstract][Full Text] [Related]
3. Recent advances relating to the clinical application of naked monoclonal antibodies in solid tumors.
Argyriou AA; Kalofonos HP
Mol Med; 2009; 15(5-6):183-91. PubMed ID: 19305491
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies in human cancer.
Mellstedt H
Drugs Today (Barc); 2003; 39 Suppl C():1-16. PubMed ID: 14988743
[TBL] [Abstract][Full Text] [Related]
5. Integration of novel agents in the treatment of colorectal cancer.
Iqbal S; Lenz HJ
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S32-9. PubMed ID: 15309512
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on anti-HER monoclonal antibodies.
Ranson M; Sliwkowski MX
Oncology; 2002; 63 Suppl 1():17-24. PubMed ID: 12422051
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review.
Tol J; Punt CJ
Clin Ther; 2010 Mar; 32(3):437-53. PubMed ID: 20399983
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
Baselga J; Norton L; Masui H; Pandiella A; Coplan K; Miller WH; Mendelsohn J
J Natl Cancer Inst; 1993 Aug; 85(16):1327-33. PubMed ID: 8340945
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with monoclonal antibodies to epidermal growth factor receptor.
Calvo E; Rowinsky EK
Curr Oncol Rep; 2005 Mar; 7(2):96-103. PubMed ID: 15717942
[TBL] [Abstract][Full Text] [Related]
10. The ErbB receptors as targets for breast cancer therapy.
Albanell J; Baselga J
J Mammary Gland Biol Neoplasia; 1999 Oct; 4(4):337-51. PubMed ID: 10705918
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody-based targeted therapy in breast cancer.
Altundag K; Esteva FJ; Arun B
Curr Med Chem Anticancer Agents; 2005 Mar; 5(2):99-106. PubMed ID: 15777217
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody therapy for prostate cancer.
Jakobovits A
Handb Exp Pharmacol; 2008; (181):237-56. PubMed ID: 18071949
[TBL] [Abstract][Full Text] [Related]
13. Targeted cancer therapies based on antibodies directed against epidermal growth factor receptor: status and perspectives.
Zhu Z
Acta Pharmacol Sin; 2007 Sep; 28(9):1476-93. PubMed ID: 17723181
[TBL] [Abstract][Full Text] [Related]
14. Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide.
Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; Pepe S; Bianco AR; Agrawal S; Mendelsohn J; Tortora G
J Natl Cancer Inst; 1998 Jul; 90(14):1087-94. PubMed ID: 9672257
[TBL] [Abstract][Full Text] [Related]
15. Development of monoclonal antibodies for the treatment of colorectal cancer.
Goodin S
Am J Health Syst Pharm; 2008 Jun; 65(11 Suppl 4):S3-7; quiz S22-4. PubMed ID: 18499888
[TBL] [Abstract][Full Text] [Related]
16. [Principal therapeutic uses of monoclonal antibodies in oncology].
Penault-Llorca F; Etessami A; Bourhis J
Cancer Radiother; 2002 Nov; 6 Suppl 1():24s-28s. PubMed ID: 12587379
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
[TBL] [Abstract][Full Text] [Related]
18. The EGF receptor family as targets for cancer therapy.
Mendelsohn J; Baselga J
Oncogene; 2000 Dec; 19(56):6550-65. PubMed ID: 11426640
[TBL] [Abstract][Full Text] [Related]
19. Targeting a unique EGFR epitope with monoclonal antibody 806 activates NF-kappaB and initiates tumour vascular normalization.
Gan HK; Lappas M; Cao DX; Cvrljevdic A; Scott AM; Johns TG
J Cell Mol Med; 2009 Sep; 13(9B):3993-4001. PubMed ID: 19432811
[TBL] [Abstract][Full Text] [Related]
20. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
Harding J; Burtness B
Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
